Autopsy report · NCT03059563

Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users

“Global pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 5 years 9 months before it stopped.
• 62 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of California, Los Angeles

Sponsor type

University, hospital or other

Conditions

Dopamine D2/3 Receptor Availability; Cognitive Function; Methamphetamine Abuse

Interventions

Varenicline; Placebo

Participants

62

Sites

1

Countries

United States

Trials that died the same way

• Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases
  “Pandemic” (89% match in meaning)
• Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV
  “COVID pandemic” (80% match in meaning)
• Convergent and Concurrent Validity Between Clinical Recovery and Personal-civic Recovery in Mental Health
  “COVID-19 pandemic” (73% match in meaning)
• Brief-Illness Perception Questionnaire (Brief-IPQ) Used in Patients With Chronic Non-malignant Pain.
  “Corona pandemic” (73% match in meaning)
• Early Kangaroo Mother Care in Gambian Hospitalised Unstable Neonates
  “In response to COVID pandemic” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.